BKI-1369 Catalog No.:M31153-C G1T28-1) is a highly potent

G1T28-1) is a highly potent

05) do not differ between the AAA model group and Tauroursodeoxycholate group

Fabesetron (FK1052) is an orally active 5-HT3 receptor antagonist with 5-HT4 receptor antagonistic activity

blocking proteolytic activation of Notch receptors

InChiKey: MQIUGAXCHLFZKX-AMEAAFLOSA-N

BKI-1369 Catalog No.:M31153-C G1T28-1) is a highly potentBKI 1369 is a bumped kinase inhibitor (BKI). BKI 1369 increases human Ether a go go related gene (hERG) inhibitory activity with an IC50 of 1. 52 M. BKI 1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI 1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves. Product information CAS Number: 1951431 22 3 Molecular